These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28888181)

  • 41. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First trimester screening for preeclampsia.
    Papageorghiou AT; Campbell S
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):594-600. PubMed ID: 17099328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a nomogram to predict occurrence of preeclampsia.
    Deis S; Rouzier R; Kayem G; Masson C; Haddad B
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):146-51. PubMed ID: 17669579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.
    Crovetto F; Crispi F; Scazzocchio E; Mercade I; Meler E; Figueras F; Gratacos E
    Ultrasound Obstet Gynecol; 2014 Jan; 43(1):34-40. PubMed ID: 23754253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; Wright A; Akolekar R; Cicero S; Janga D; Jani J; Molina FS; de Paco Matallana C; Papantoniou N; Persico N; Plasencia W; Singh M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):751-755. PubMed ID: 28067011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
    Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. External Validation Study of First Trimester Obstetric Prediction Models (Expect Study I): Research Protocol and Population Characteristics.
    Meertens LJE; Scheepers HC; De Vries RG; Dirksen CD; Korstjens I; Mulder AL; Nieuwenhuijze MJ; Nijhuis JG; Spaanderman ME; Smits LJ
    JMIR Res Protoc; 2017 Oct; 6(10):e203. PubMed ID: 29074472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microvascular remodelling in preeclampsia: quantifying capillary rarefaction accurately and independently predicts preeclampsia.
    Antonios TF; Nama V; Wang D; Manyonda IT
    Am J Hypertens; 2013 Sep; 26(9):1162-9. PubMed ID: 23757401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. External validity of first-trimester algorithms in the prediction of pre-eclampsia disease severity.
    Oliveira N; Doyle LE; Atlas RO; Jenkins CB; Blitzer MG; Baschat AA
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):286-92. PubMed ID: 24912952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First- and second-trimester screening for preeclampsia and intrauterine growth restriction.
    Tuuli MG; Odibo AO
    Clin Lab Med; 2010 Sep; 30(3):727-46. PubMed ID: 20638585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction.
    Rodriguez A; Tuuli MG; Odibo AO
    Clin Lab Med; 2016 Jun; 36(2):331-51. PubMed ID: 27235916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. External validation of models and simple scoring systems to predict miscarriage in intrauterine pregnancies of uncertain viability.
    Guha S; Van Belle V; Bottomley C; Preisler J; Vathanan V; Sayasneh A; Stalder C; Timmerman D; Bourne T
    Hum Reprod; 2013 Nov; 28(11):2905-11. PubMed ID: 23980057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First trimester uterine artery Doppler for the prediction of preeclampsia and foetal growth restriction.
    Carbillon L
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):877-83. PubMed ID: 21740323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.
    Akkermans J; Payne B; von Dadelszen P; Groen H; Vries Jd; Magee LA; Mol BW; Ganzevoort W
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():58-62. PubMed ID: 24965981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysis.
    Kleinrouweler CE; Bossuyt PM; Thilaganathan B; Vollebregt KC; Arenas Ramírez J; Ohkuchi A; Deurloo KL; Macleod M; Diab AE; Wolf H; van der Post JA; Mol BW; Pajkrt E
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):257-67. PubMed ID: 23417857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.